Publications | Lund University Publications

1 – 10 of 17

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hjorth-Hansen%2C+Henrik%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hjorth-Hansen%2C+Henrik%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2024
Mark Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
Huuhtanen, Jani ; Adnan-Awad, Shady ; Theodoropoulos, Jason ; Forstén, Sofia ; Warfvinge, Rebecca ^LU ; Dufva, Olli ; Bouhlal, Jonas ; Dhapola, Parashar ^LU ; Duàn, Hanna and Laajala, Essi , et al. (2024) In Leukemia 38(1). p.109-125
- Contribution to journal › Article
2021
Mark Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP : Five-year follow-up of the NordCML007 study
Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper ; Richter, Johan ^LU ; Koskenvesa, Perttu ; Mustjoki, Satu ; Majeed, Waleed ; Lübking, Anna ^LU ; Dreimane, Arta and Markevärn, Berit , et al. (2021) In European Journal of Haematology 107(6). p.617-623
- Contribution to journal › Article
2020
Mark Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy
Söderlund, Stina ; Persson, Inger ; Ilander, Mette ; Guilhot, Joëlle ; Hjorth-Hansen, Henrik ; Koskenvesa, Perttu ; Richter, Johan ^LU ; Saussele, Susanne ; Mustjoki, Satu and Olsson-Strömberg, Ulla (2020) In Leukemia Research 90.
- Contribution to journal › Article
2019
Mark Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Kreutzman, Anna ; Yadav, Bhagwan ; Brummendorf, Tim H. ; Gjertsen, Bjorn Tore ; Lee Hee, Moon ; Janssen, Jeroen ; Kasanen, Tiina ; Koskenvesa, Perttu ; Lofti, Kourosh and Markevärn, Berit , et al. (2019) In OncoImmunology 8(9).
- Contribution to journal › Article
2018
Mark CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
Landberg, Niklas ^LU ; von Palffy, Sofia ^LU ; Askmyr, Maria ^LU ; Lilljebjörn, Henrik ^LU ; Sandén, Carl ^LU ; Rissler, Marianne ^LU ; Mustjoki, Satu ; Hjorth-Hansen, Henrik ; Richter, Johan ^LU and Ågerstam, Helena ^LU , et al. (2018) In Haematologica 103(3). p.447-455
- Contribution to journal › Article
Mark Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI) : a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Saussele, Susanne ; Richter, Johan ^LU ; Guilhot, Joelle ; Gruber, Franz X. ; Hjorth-Hansen, Henrik ; Almeida, Antonio ; Janssen, Jeroen J.W.M. ; Mayer, Jiri ; Koskenvesa, Perttu and Panayiotidis, Panayiotis , et al. (2018) In The Lancet Oncology 19(6). p.747-757
- Contribution to journal › Article
2017
Mark Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
Warfvinge, Rebecca ^LU ; Geironson Ulfsson, Linda ^LU ; Sommarin, Mikael N E ^LU ; Lang, Stefan ^LU ; Karlsson, Christine ^LU ; Roschupkina, Teona ^LU ; Stenke, Leif ; Stentoft, Jesper ; Olsson-Strömberg, Ulla and Hjorth-Hansen, Henrik , et al. (2017) In Blood 129(17). p.2384-2394
- Contribution to journal › Article
Mark Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
Rajala, Hanna L M ; El Missiry, Mohamed ; Ruusila, Anniina ; Koskenvesa, Perttu ; Brümmendorf, Tim H. ; Gjertsen, Bjorn T. ; Janssen, Jeroen Jwm ; Lotfi, Kourosh ; Markevärn, Berit and Olsson-Strömberg, Ulla , et al. (2017) In Journal of Cancer Research and Clinical Oncology 143(8). p.1543-1554
- Contribution to journal › Article
2016
Mark Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli
Söderlund, Stina ; Christiansson, Lisa ; Persson, Inger ; Hjorth-Hansen, Henrik ; Richter, Johan ^LU ; Simonsson, Bengt ; Mustjoki, Satu ; Olsson-Strömberg, Ulla and Loskog, Angelica (2016) In Leukemia Research 50. p.95-103
- Contribution to journal › Article
Mark Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
El Missiry, Mohamed ; Adnan Awad, Shady ; Rajala, Hanna L ; Al-Samadi, Ahmed ; Ekblom, Marja ^LU ; Markevän, Berit ; Åstrand-Grundström, Ingbritt ^LU ; Wold, Maren ; Svedahl, Ellen Rabben and Juhl, Birgitte Ravn , et al. (2016) In Journal of Cancer Research and Clinical Oncology 142(5). p.1041-1050
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove author: Hjorth-Hansen, Henrik